XML 41 R29.htm IDEA: XBRL DOCUMENT v3.24.4
Stockholders' Equity (Tables)
6 Months Ended
Dec. 31, 2024
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

Three Months Ended December 31, 

    

Six Months Ended December 31, 

    

2023

    

2024

2023

    

2024

Cost of goods sold

$

255

$

226

$

487

$

470

Selling, general and administrative

6,945

8,142

13,676

14,166

Research and development

128

141

254

295

Stock-based compensation expense

$

7,328

$

8,509

$

14,417

$

14,931

Schedule of stock option activity

Weighted

Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2024

 

78,958

 

$

97.87

 

Granted

 

15,531

174.63

Exercised

 

(19,210)

93.66

Expired or forfeited

 

(376)

$

106.70

Outstanding at December 31, 2024

 

74,903

$

114.82

7.8 years

$

4,053

Exercisable at December 31, 2024

37,305

$

93.41

 

6.5 years

$

2,761

Summary of RSU award activity

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2024

 

391,591

$

99.21

Granted

 

294,932

150.70

Vested

 

(322,406)

127.92

Forfeited

 

(3,375)

100.04

Nonvested at December 31, 2024

 

360,742

$

115.65